戈尔吉凝结导致肠道脂质通过NEDD4通过HIF-1α介导的GM130无所不在的积累NEDD4通过GM130的积累
Hyunsoo Kim1, Channy Park1, Xiaofan Wei1
1Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
Experimental & molecular medicine
|February 3, 2025
概括
缺氧导致戈尔吉蛋白降解,导致戈尔吉凝结和小肠中的脂质积累. 抑制缺氧诱导因子1α (HIF-1α) 或NEDD4可以防止这种情况,减少脂质积累并改善脂质分泌.
科学领域:
- 细胞生物学 细胞生物学
- 胃肠病学 胃肠病学
- 代谢疾病 代谢疾病
背景情况:
- 戈尔吉蛋白质的分解破坏了脂质的流通,导致肠道脂质的积累.
- 在这些条件下,将戈尔吉结构变化与脂质贩运缺陷联系在一起的确切机制尚不清楚.
研究的目的:
- 调查戈尔吉蛋白降解在脂质贩运中的作用以及小肠中的戈尔吉结构变化.
- 阐明低氧诱导的戈尔吉变化背后的分子机制及其对脂质代谢的影响.
主要方法:
- 在低氧条件下研究高脂肪饮食养的小鼠.
- 研究了低氧诱导因子1α (HIF-1α),NEDD4和戈尔吉矩阵蛋白130 (GM130) 在戈尔吉凝结中的作用.
- 使用药理抑制剂 (PX-478) 和基因操纵来评估对脂质积累和分泌的影响.
主要成果:
- 低氧会诱导小肠中的戈尔吉蛋白降解和结构变化 ("戈尔吉凝结").
- HIF-1α激活通过NEDD4介导的GM130无处不在和降解促进戈尔吉凝结.
- 戈尔吉凝结损害了脂质的流通,导致脂质的积累和减少了胆米克朗的分泌.
- 抑制HIF-1α或NEDD4可以逆转戈尔吉凝结,减少脂质积累,增强阿波利波蛋白A1分泌.
结论:
- 戈尔吉凝结是由HIF-1α和NEDD4介导的GM130降解驱动的,是肠道脂质积累的关键因素.
- 针对戈尔吉结构修饰提供了一个潜在的治疗策略,用于管理肥胖的肠道脂质积累.
相关概念视频
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Transport Across the Golgi
4.0K
While it is unclear how molecules move between adjacent Golgi cisternae, it is apparent that the molecules move from cis- cisterna, the entry face, to the trans- cisterna, the exit face. Experiments initially suggested vesicles that bud from one cisterna and fuse with the next cisterna to transport proteins between the cisternae. This vesicular transport model describes the Golgi apparatus as a relatively static structure with a unique enzyme composition in each cisterna. Molecules are...
4.0K
Lipid Absorption
354
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
354
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
Intralumenal Vesicles and Multivesicular Bodies
3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K


